NBOMe-mescaline

NBOMe-mescaline
Clinical data
Other namesMescaline-NBOMe; 345-NBOMe; M-NBOMe; NBOMe-M; N-(2-Methoxybenzyl)-3,4,5-trimethoxyphenethylamine; 3,4,5-Trimethoxy-N-(2-methoxybenzyl)phenethylamine
Routes of
administration		Oral, others
Drug classSerotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
  • US: Unscheduled
Pharmacokinetic data
Duration of action~2–3 hours
Identifiers
  • N-(2-Methoxybenzyl)-2-(3,4,5-trimethoxyphenyl)ethan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H25NO4
Molar mass331.412 g·mol−1
3D model (JSmol)
  • COC1=CC(CCNCC2=C(OC)C=CC=C2)=CC(OC)=C1OC.Cl
  • InChI=1S/C19H25NO4/c1-21-16-8-6-5-7-15(16)13-20-10-9-14-11-17(22-2)19(24-4)18(12-14)23-3/h5-8,11-12,20H,9-10,13H2,1-4H3 Y
  • Key:USPSMWCGHVXKMN-UHFFFAOYSA-N Y

NBOMe-mescaline, also known as mescaline-NBOMe, M-NBOMe, or N-(2-methoxybenzyl)-3,4,5-trimethoxyphenethylamine, is a serotonin receptor agonist and putative psychedelic drug of the phenethylamine, scaline, and N-benzylphenethylamine (NBOMe) families. It is the N-(2-methoxybenzyl) derivative of mescaline.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.